Alnylam Pharmaceuticals, Inc.

ONPATTRO

  1. Home
  2.  / 
  3. J Code
  4.  / ONPATTRO – J0222

Manufacturer:

Alnylam Pharmaceuticals, Inc.

Name:

ONPATTRO

HCPCS Code Descriptor:

Injection, patisiran, 0.1 mg

Category:

J Code

HCPCS:

J0222

NDC(s):

71336-1000-01

Primary Type:

Genetic Disorder

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ONPATTRO is a Genetic Disorder drug manufactured by Alnylam Pharmaceuticals, Inc. and administered via the Intravenous route of administration. The J Code: J0222 is aligned to the drug ONPATTRO.

Access Pricing and More By Registering

HCPCS Added Date:

10/1/19

HCPCS Effective Date:

10/1/19

HCPCS Short Description:

Inj., patisiran, 0.1 mg

Billing and Coding Guide:

https://www.onpattrohcp.com/files/pdfs/ONPATTRO-Billing-Coding-Guide-for-Physicians.pdf, https://www.onpattrohcp.com/files/pdfs/ONPATTRO-Billing-Coding-Guide-for-Hospitals.pdf

Patient Assistance:

https://www.alnylamassist.com/